{"product_id":"inflammation-from-molecular-and-cellular-mechanisms-to-the-clinic","title":"Inflammation: From Molecular and Cellular Mechanisms to the Clinic","description":"\u003cdiv id=\"bookDescription_feature_div\" class=\"celwidget\" data-feature-name=\"bookDescription\" data-csa-c-type=\"widget\" data-csa-c-content-id=\"bookDescription\" data-csa-c-slot-id=\"bookDescription_feature_div\" data-csa-c-asin=\"0993745598\" data-csa-c-is-in-initial-active-row=\"false\" data-csa-c-id=\"7y9w7h-rgk3d4-2xixgp-6jetc1\" data-cel-widget=\"bookDescription_feature_div\"\u003e\n\u003cdiv data-a-expander-name=\"book_description_expander\" data-a-expander-collapsed-height=\"280\" class=\"a-expander-collapsed-height a-row a-expander-container a-spacing-base a-expander-partial-collapse-container\"\u003e\n\u003cdiv aria-expanded=\"false\" class=\"a-expander-content a-expander-partial-collapse-content\"\u003e\n\u003cdiv data-cel-widget=\"bookDescription_feature_div\" data-csa-c-id=\"3xu427-hdulpm-xey1d9-kajk0v\" data-csa-c-is-in-initial-active-row=\"false\" data-csa-c-asin=\"1975136373\" data-csa-c-slot-id=\"bookDescription_feature_div\" data-csa-c-content-id=\"bookDescription\" data-csa-c-type=\"widget\" data-feature-name=\"bookDescription\" class=\"celwidget\" id=\"bookDescription_feature_div\"\u003e\n\u003cdiv class=\"a-expander-collapsed-height a-row a-expander-container a-spacing-base a-expander-partial-collapse-container\" data-a-expander-collapsed-height=\"280\" data-a-expander-name=\"book_description_expander\"\u003e\n\u003cdiv class=\"a-expander-content a-expander-partial-collapse-content\" aria-expanded=\"false\"\u003e\n\u003cdiv id=\"bookDescriptionBox\" class=\"expanded\"\u003eStarting with the molecular basis of inflammation, the book continues with inflammation in infectious diseases and the relationship between inflammation and chronic diseases. The final part of the work is devoted to tissue healing and options for therapeutic interventions.\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cdiv class=\"bookDetailsBox\"\u003e\n\u003cdiv class=\"bookProperty property_categories\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTable of Contents\u003c\/strong\u003e\u003cbr\u003eGO TO PART\u003cbr\u003eExport Citation(s)\u003cbr\u003eFront Matter (Pages: i-xlvi)\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eCHAPTER 1\u003cbr\u003eInflammation through the Ages: A Historical Perspective (Pages: 1-16)\u003cbr\u003eJean-Marc Cavaillon\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003ePart One : Inducers and Sensors of Inflammation\u003cbr\u003eCHAPTER 2\u003cbr\u003ePathogen-associated Molecular Patterns (Pages: 17-56)\u003cbr\u003eJean-Marc Cavaillon\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eCHAPTER 3\u003cbr\u003eDamage-associated Molecular Patterns (Pages: 57-80)\u003cbr\u003eJean-Marc Cavaillon\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003eCHAPTER 4\u003cbr\u003eBacterial Toxins (Pages: 81-98)\u003cbr\u003eMarina de Bernard,  Cesare Montecucco\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eCHAPTER 5\u003cbr\u003eVenoms (Pages: 99-128)\u003cbr\u003eCatarina Teixeira,  Vanessa Moreira,  José María Gutiérrez\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eCHAPTER 6\u003cbr\u003eHypoxia as an Inducer of Inflammation (Pages: 129-142)\u003cbr\u003eAriel Brandwein,  Clifford S. Deutschman\u003c\/p\u003e\n\u003cp\u003eReferences\u003cbr\u003eRequest permissions\u003cbr\u003eCHAPTER 7\u003cbr\u003eVaccine Adjuvants (Pages: 143-174)\u003cbr\u003eDennis M. Klinman,  Hidekazu Shirota\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eCHAPTER 8\u003cbr\u003ePattern Recognition Receptors (Pages: 175-216)\u003cbr\u003eLauren Whitehead,  Gordon D. Brown\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003ePart Two : Inflammatory Cells\u003cbr\u003eCHAPTER 9\u003cbr\u003eMonocytes and Macrophages (Pages: 217-252)\u003cbr\u003eIrina N. Shalova,  Shilpi Saha,  Subhra K. Biswas\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eCHAPTER 10\u003cbr\u003eNeutrophils (Pages: 253-272)\u003cbr\u003eSalvatore Cuzzocrea\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003eCHAPTER 11\u003cbr\u003eMast Cells: Master Drivers of Immune Responses against Pathogens (Pages: 273-288)\u003cbr\u003eW.X. Gladys Ang,  Soman N. Abraham\u003c\/p\u003e\n\u003cp\u003eCHAPTER 12\u003cbr\u003eDendritic Cells in Inflammatory Disease (Pages: 289-314)\u003cbr\u003eBart N. Lambrecht,  Martin Guilliams,  Hamida Hammad\u003c\/p\u003e\n\u003cp\u003eReferences\u003cbr\u003eRequest permissions\u003cbr\u003eCHAPTER 13\u003cbr\u003eRoles for NK Cells and ILC1 in Inflammation and Infection (Pages: 315-340)\u003cbr\u003eChristian A.J. Vosshenrich,  James P. Di Santo\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eCHAPTER 14\u003cbr\u003eGroup 2 and 3 Innate Lymphoid Cells: New Actors in Immunity and Inflammation (Pages: 341-364)\u003cbr\u003eNicolas Serafini,  James P. Di Santo\u003c\/p\u003e\n\u003cp\u003eCHAPTER 15\u003cbr\u003eTh9 Cells: From the Bench to the Bedside and Back Again (Pages: 365-394)\u003cbr\u003eBenjamin J. Ulrich,  Matthew M. Hufford,  Mark H. Kaplan\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eCHAPTER 16\u003cbr\u003eTh17 Cells (Pages: 395-418)\u003cbr\u003eMélissa Noack,  Pierre Miossec\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eCHAPTER 17\u003cbr\u003ePlatelets (Pages: 419-436)\u003cbr\u003eJack Levin\u003c\/p\u003e\n\u003cp\u003eCHAPTER 18\u003cbr\u003eEpithelial Cells (Pages: 437-456)\u003cbr\u003eJill M. Hoffman,  Charalabos Pothoulakis\u003c\/p\u003e\n\u003cp\u003eReferences\u003cbr\u003eRequest permissions\u003cbr\u003eCHAPTER 19\u003cbr\u003eInflammation: The Role of Endothelial Cells (Pages: 457-476)\u003cbr\u003eJ. Steven Alexander,  D. Neil Granger,  Norman R. Harris\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003ePart Three : Inflammatory Mediators\u003cbr\u003eCHAPTER 20\u003cbr\u003eIL-1 Superfamily and Inflammasome (Pages: 477-528)\u003cbr\u003eCharles A. Dinarello\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eCHAPTER 21\u003cbr\u003eTNF Superfamily (Pages: 529-547)\u003cbr\u003eSalvatore Cuzzocrea\u003c\/p\u003e\n\u003cp\u003eCHAPTER 22\u003cbr\u003eInterleukin-17 A-E (Pages: 549-572)\u003cbr\u003eGiovanni Monteleone,  Irene Marafini,  Edoardo Troncone\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eCHAPTER 23\u003cbr\u003eIL-6 Superfamily (Pages: 573-586)\u003cbr\u003eToshio Tanaka,  Masashi Narazaki,  Tadamistu Kishimoto\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eCHAPTER 24\u003cbr\u003eType I and II Cytokine Superfamilies in Inflammatory Responses (Pages: 587-618)\u003cbr\u003eWilliam F. Carson IV,  Steven L. Kunkel\u003c\/p\u003e\n\u003cp\u003eReferences\u003cbr\u003eRequest permissions\u003cbr\u003eCHAPTER 25\u003cbr\u003eChemokines and Chemotaxis (Pages: 619-650)\u003cbr\u003eOsamu Yoshie,  Kouji Matsushima\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eCHAPTER 26\u003cbr\u003eLipid Mediators in Inflammation (Pages: 651-694)\u003cbr\u003eShuh Narumiya,  Takehiko Yokomizo,  Junken Aoki\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003eCHAPTER 27\u003cbr\u003eFree Radicals in Inflammation (Pages: 695-726)\u003cbr\u003eAndrew Cumpstey,  Martin Feelisch\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eCHAPTER 28\u003cbr\u003eProteases (Pages: 727-766)\u003cbr\u003eCeline Deraison,  Chrystelle Bonnart,  Nathalie Vergnolle\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eCHAPTER 29\u003cbr\u003ePsychiatric Disorders and Inflammation (Pages: 767-784)\u003cbr\u003eRobert Dantzer\u003c\/p\u003e\n\u003cp\u003eReferences\u003cbr\u003eRequest permissions\u003cbr\u003eCHAPTER 30\u003cbr\u003eComplement System (Pages: 785-812)\u003cbr\u003ePeter A. Ward,  Claudia Kemper\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eCHAPTER 31\u003cbr\u003eHeat Shock Proteins (Pages: 813-830)\u003cbr\u003eWillem van Eden,  Femke Broere,  Ruurd van der Zee\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003ePart Four : Inflammation and Host Response\u003cbr\u003eCHAPTER 32\u003cbr\u003eInflammation and Coagulation (Pages: 833-860)\u003cbr\u003eMarcel Levi\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eCHAPTER 33\u003cbr\u003eFever: Mediators and Mechanisms (Pages: 861-890)\u003cbr\u003eJoachim Roth\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eCHAPTER 34\u003cbr\u003ePain (Pages: 891-914)\u003cbr\u003eChristoph Stein\u003c\/p\u003e\n\u003cp\u003eReferences\u003cbr\u003eRequest permissions\u003cbr\u003eCHAPTER 35\u003cbr\u003eInflammation, Hormones, and Metabolism (Pages: 915-946)\u003cbr\u003eMuska Khpal,  Mervyn Singer\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eCHAPTER 36\u003cbr\u003eMicroenvironmental Regulation of Innate Immune Cell Function (Pages: 947-970)\u003cbr\u003eEmily R. Watts,  Eilise Ryan,  Sarah R. Walmsley,  Moira K.B. Whyte\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eCHAPTER 37\u003cbr\u003eEpigenetics of Inflammation (Pages: 971-992)\u003cbr\u003eVidula Vachharajani,  Charles E. McCall\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003ePart Five : Inflammation and Diseases\u003cbr\u003eCHAPTER 38\u003cbr\u003eAllergy and Inflammation (Pages: 995-1030)\u003cbr\u003eMilena Sokołowska,  Anna Głobińska,  Cezmi A. Akdis\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eCHAPTER 39\u003cbr\u003eSepsis (Pages: 1031-1052)\u003cbr\u003eManu Shankar-Hari,  Mervyn Singer\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003eCHAPTER 40\u003cbr\u003eAutoimmunity and Inflammation (Pages: 1053-1090)\u003cbr\u003eShrikant Ramesh Mulay,  Onkar P. Kulkarni,  Khader Rupanagudi,  Hans-Joachim Anders\u003c\/p\u003e\n\u003cp\u003eReferences\u003c\/p\u003e\n\u003cp\u003eCHAPTER 41\u003cbr\u003ePsoriasis and Other Skin Inflammatory Diseases (Pages: 1091-1104)\u003cbr\u003eJaehwan Kim,  James G. Krueger\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003eCHAPTER 42\u003cbr\u003eRheumatoid Arthritis and Other Inflammatory Articular Diseases (Pages: 1105-1140)\u003cbr\u003eRogier M. Thurlings,  Sander W. Tas,  Paul Peter Tak*\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003eCHAPTER 43\u003cbr\u003eMissing Heritability of Crohn's Disease and Implications for Therapeutic Targeting and Improved Care (Pages: 1141-1146)\u003cbr\u003eMatthias Chamaillard\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003eCHAPTER 44\u003cbr\u003eInflammation and Transplantation (Pages: 1147-1172)\u003cbr\u003eWilliam M. Baldwin, III,  Robert L. Fairchild\u003c\/p\u003e\n\u003cp\u003eReferences\u003c\/p\u003e\n\u003cp\u003eCHAPTER 45\u003cbr\u003eInflammatory Mechanisms in Chronic Obstructive Pulmonary Disease (Pages: 1173-1198)\u003cbr\u003ePeter J. Barnes\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003eCHAPTER 46\u003cbr\u003eObesity: A Complex Disease with Immune Components (Pages: 1199-1224)\u003cbr\u003eYuejun Liu,  Karine Clément\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eCHAPTER 47\u003cbr\u003eInflammation and Type 2 Diabetes (Pages: 1225-1254)\u003cbr\u003eMarleen M.J. van Greevenbroek,  Casper G. Schalkwijk,  Coen D.A. Stehouwer\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eCHAPTER 48\u003cbr\u003eInflammation-Mediated Neurodegeneration: Models, Mechanisms, and Therapeutic Interventions for Neurodegenerative Diseases (Pages: 1255-1278)\u003cbr\u003eHui-Ming Gao,  Yun Gao,  Dezhen Tu,  Yue Liu,  Hui Zhou,  Jau-Shyong Hong\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eCHAPTER 49\u003cbr\u003eInflammation in Atherosclerosis (Pages: 1279-1300)\u003cbr\u003eMario A.R. Lauterbach,  Larisa I. Labzin,  Eicke Latz\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eCHAPTER 50\u003cbr\u003eAcute Kidney Injury (Pages: 1301-1312)\u003cbr\u003eJohan Mårtensson,  Rinaldo Bellomo\u003c\/p\u003e\n\u003cp\u003eReferences\u003c\/p\u003e\n\u003cp\u003eCHAPTER 51\u003cbr\u003eIschemia–Reperfusion Syndrome (Pages: 1313-1328)\u003cbr\u003eChristophe Adrie,  Sally A. Shin,  Mehran Monchi\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003eCHAPTER 52\u003cbr\u003eSingle-Nucleotide Polymorphisms and Inflammation (Pages: 1329-1346)\u003cbr\u003eEvangelos J. Giamarellos-Bourboulis\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003ePart Six : Resolution of Inflammation and Tissue Repair\u003cbr\u003eCHAPTER 53\u003cbr\u003ePentraxins in the Orchestration of Defense and Tissue Repair during the Acute Phase Response (Pages: 1347-1362)\u003cbr\u003eAlberto Mantovani,  Cecilia Garlanda,  Barbara Bottazzi\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003eCHAPTER 54\u003cbr\u003eAnti-Inflammatory Cytokines, Soluble Receptors, and Natural Antagonists (Pages: 1363-1376)\u003cbr\u003eWillem Joost Wiersinga,  Tom van der Poll\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003eCHAPTER 55\u003cbr\u003eRegulatory T Cells (Pages: 1377-1422)\u003cbr\u003eLuciana Berod,  Katharina Lahl,  Matthias Lochner,  Christian T. Mayer,  Tim Sparwasser\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003eCHAPTER 56\u003cbr\u003eLeukocyte Reprogramming (Pages: 1423-1446)\u003cbr\u003eJean-Marc Cavaillon\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003eCHAPTER 57\u003cbr\u003eRoles of Specialized Proresolving Lipid Mediators in Inflammation Resolution and Tissue Repair (Pages: 1447-1466)\u003cbr\u003eMatthew Spite,  Charles N. Serhan\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eCHAPTER 58\u003cbr\u003eGlucocorticoids (Pages: 1467-1484)\u003cbr\u003eHeming Nicholas,  Annane Djillali\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003eCHAPTER 59\u003cbr\u003eThe Neuroimmune Communicatome in Inflammation (Pages: 1485-1516)\u003cbr\u003ePeder S. Olofsson,  Christine N. Metz,  Valentin A. Pavlov\u003cbr\u003eSummary\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003eThe Inflammatory Response in Tissue Repair (Pages: 1517-1538)\u003cbr\u003eNikolaos G. Frangogiannis\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003ePart Seven : Detection and Treatments\u003cbr\u003eCHAPTER 61\u003cbr\u003eBiomarkers in Inflammation (Pages: 1539-1566)\u003cbr\u003eAndreas Kortgen,  Michael Bauer\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eCHAPTER 62\u003cbr\u003eIn Vivo Imaging of Inflammation (Pages: 1567-1582)\u003cbr\u003eAnne Roivainen,  Antti Saraste\u003cbr\u003eSummary\u003c\/p\u003e\n\u003cp\u003eCHAPTER 63\u003cbr\u003eNovel Targets for Drug Development (Pages: 1583-1608)\u003cbr\u003eAlan S. Cross,  Steven M. Opal\u003c\/p\u003e\n\u003cp\u003eCHAPTER 64\u003cbr\u003eInflammation and Microbiota and Gut Reconditioning (Pages: 1609-1660)\u003cbr\u003eStig Bengmark\u003c\/p\u003e\n\u003cp\u003eCHAPTER 65\u003cbr\u003eNatural Products as Source of Anti-Inflammatory Drugs (Pages: 1661-1690)\u003cbr\u003eShivaprasad H. Venkatesha,  Bodhraj Acharya,  Kamal D. Moudgil\u003cbr\u003e\u003c\/p\u003e\n\u003cdiv id=\"editorialReviews_feature_div\" class=\"celwidget\" data-feature-name=\"editorialReviews\" data-csa-c-type=\"widget\" data-csa-c-content-id=\"editorialReviews\" data-csa-c-slot-id=\"editorialReviews_feature_div\" data-csa-c-asin=\"\" data-csa-c-is-in-initial-active-row=\"false\" data-csa-c-id=\"3uahp4-2kz8m5-cktmzy-bg0xyf\" data-cel-widget=\"editorialReviews_feature_div\"\u003e\n\u003cdiv class=\"a-section a-spacing-small a-padding-base\"\u003e\n\u003ch3\u003e\u003cspan\u003eAbout the Author\u003c\/span\u003e\u003c\/h3\u003e\n\u003cdiv class=\"a-section a-spacing-small a-padding-small\"\u003e\u003cspan\u003eJean-Marc Cavaillon is professor and Head of the Unit \"Cytokines and Inflammation\" at Institut Pasteur (Paris). He has been President of the \"International Endotoxin and Innate Immunity Society\". He is member of the Editorial Boards of few journals including Shock, Journal of Infectious Diseases, and International Journal of Inflammation, and has been Associate-Editor of \"Cytokine\" (2002-2009).\u003cbr\u003eJean-Marc Cavaillon has an extensive expertise in innate immunity, particularly on cytokines, inflammation, bacterial endotoxins and other Toll-like receptors agonists, endotoxin tolerance, activation of monocytes\/macrophages and neutrophils, altered immune status in sepsis and SIRS patients. He is the co-author of a book \"Sepsis and non-infectious inflammation: from biology to critical care\" (Wiley VCH, 2009) and the author of a book in French on cytokines (Masson, 1993 \u0026amp; 1996) . Jean-Marc Cavaillon has published 145 scientific articles, 77 reviews and 45 chapters in books.\u003cbr\u003e\u003cbr\u003eMervyn Singer is Professor of Intensive Care Medicine at University College London. His primary research interests are sepsis and multi-organ failure, infection, shock and haemodynamic monitoring. Funding for these activities primarily comes from the Wellcome Trust, Medical Research Council and National Institute for Health Research. He developed an oesophageal Doppler haemodynamic monitor that is now in widespread use worldwide, the use of which has been shown in multiple studies to improve outcomes after major surgery and reduce length of stay. He has led on a number of important multi-centre trials in critical care. He has authored various papers and textbooks including the Oxford Handbook of Critical Care, now in its 3rd Edition, and is a Council member of the International Sepsis Forum. He was the first UK intensivist to be awarded Senior Investigator status by the National Institute for Health Research, and to be invited to give plenary lectures at the European and US Intensive Care Congresses.\u003c\/span\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"detailBullets_feature_div\" class=\"celwidget\" data-feature-name=\"detailBullets\" data-csa-c-type=\"widget\" data-csa-c-content-id=\"detailBullets\" data-csa-c-slot-id=\"detailBullets_feature_div\" data-csa-c-asin=\"\" data-csa-c-is-in-initial-active-row=\"false\" data-csa-c-id=\"jot9c4-rf6291-algq9x-jw8fsr\" data-cel-widget=\"detailBullets_feature_div\"\u003e\n\u003cdiv id=\"detailBulletsWrapper_feature_div\" data-feature-name=\"detailBullets\" data-template-name=\"detailBullets\" class=\"a-section feature detail-bullets-wrapper bucket\" data-cel-widget=\"detailBulletsWrapper_feature_div\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cb\u003eBOOKREAD™ 5-STEP SATISFACTION GUARANTEE\u003c\/b\u003e\u003c\/strong\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003e1. No Risk, 30-Day Money-Back Guarantee. \u003cbr\u003e2. instant download. No surprises or hidden fees.\u003cbr\u003e3. Safe Payments via Credit\/Debit Card or PayPal® \u003cbr\u003e4. McAfee™ and SSL secured shopping cart.\u003cbr\u003e5. lifetime customer support.\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"My Store","offers":[{"title":"PDF","offer_id":56778120560971,"sku":null,"price":89.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1031\/1204\/8971\/files\/91cEFb407CL._SL1500.jpg?v=1773316416","url":"https:\/\/bookread.io\/products\/inflammation-from-molecular-and-cellular-mechanisms-to-the-clinic","provider":"bookread","version":"1.0","type":"link"}